• Hit and Miss in Castration-Resistant Prostate Cancer

    One year ago - By MedPageToday

    An extended progression-free interval failed to translate into better overall survival in metastatic castration-resistant prostate cancer treated with two androgen-targeted drugs instead of one, a randomized trial...
    Read more ...